Private Management Group’s iShares Biotechnology ETF IBB Stock Holding History

Private Management Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-24,944	Closed	-$2.4M	–	127
2018 Q4	$2.4M	Sell	24,944 -64,180	-72%	-$6.81M	0.13%	97
2018 Q3	$10.9M	Sell	89,124 -886	-1%	-$104K	0.51%	79
2018 Q2	$9.88M	Buy	90,010 +6,184	+7%	+$661K	0.48%	77
2018 Q1	$8.95M	Sell	83,826 -1,166	-1%	-$129K	0.48%	74
2017 Q4	$9.07M	Sell	84,992 -103	-0.1%	-$11K	0.47%	73
2017 Q3	$9.46M	Sell	85,095 -68,682	-45%	-$7.34M	0.5%	73
2017 Q2	$15.9M	Sell	153,777 -642	-0.4%	-$63.2K	0.87%	48
2017 Q1	$15.1M	Buy	154,419 +1,104	+0.7%	+$106K	0.85%	45
2016 Q4	$13.6M	Buy	153,315 +62,235	+68%	+$5.66M	0.77%	59
2016 Q3	$8.79M	Sell	91,080 -1,818	-2%	-$173K	0.54%	65
2016 Q2	$7.97M	Buy	92,898 +9,588	+12%	+$860K	0.52%	64
2016 Q1	$7.24M	Buy	+83,310	New	+$7.45M	0.46%	64

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Private Management Group's IBB Position: Q1 2019 in Review

Private Management Group sold out of iShares Biotechnology ETF (IBB) in Q1 2019, closing a stake of 24,944 shares — an estimated $2.4M sold.

Private Management Group first reported a position in IBB in Q1 2016 and held it in 12 quarters. The position peaked at $15.9M in Q2 2017. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

Private Management Group reported no remaining iShares Biotechnology ETF position as of Q1 2019 after selling out during the quarter.
Private Management Group sold 24,944 iShares Biotechnology ETF shares in Q1 2019, an estimated $2.4M.
Private Management Group first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 12 quarters.
Private Management Group's iShares Biotechnology ETF position peaked at $15.9M in Q2 2017.
670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on Private Management Group's 13F filing for Q1 2019, filed 10 May 2019.